Know a great AI tool or AI news source? Submit it to AiByts
GLP6 min read

Eating disorders are on the rise. GLP-1s could make things worse.

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders.

By Jessica HamzelouMIT Technology Review
Eating disorders are on the rise. GLP-1s could make things worse.

Read the full story

Originally published by MIT Technology Review on Oct 30, 2026.

Read on MIT Technology Review(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.